1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        SAM Mid-Size Pharmaceutical – By Type

1.3.2        SAM Mid-Size Pharmaceutical – By Drug Development Type

1.3.3        SAM Mid-Size Pharmaceutical – By Formulation

1.3.4        SAM Mid-Size Pharmaceutical – By Therapy Area

1.3.5        SAM Mid-Size Pharmaceutical – By Country

2.           South & Central America Mid-Size Pharmaceutical– Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           SAM Mid-Size Pharmaceutical – Market Landscape

4.1         Overview

4.2         SAM PEST Analysis

4.3         Expert Opinion

5.           South & Central America Mid-Size Pharmaceutical Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Rising Prevalence of Chronic Disorders

5.1.2        Increasing Product Approval and Launches

5.2         Market Restraints

5.2.1        High Competition Among Market Players

5.3         Market Opportunities

5.3.1        Rising Number of Healthcare Start-ups

5.4         Future Trends

5.4.1        Increasing Focus on R&D

5.5         Impact Analysis

6.           Mid-Size Pharmaceutical Market– SAM Analysis

6.1         SAM Mid-Size Pharmaceutical Market Revenue Forecast and Analysis

7.           SAM Mid-Size Pharmaceutical Market Revenue and Forecasts To 2028– by Type

7.1         Overview

7.2         SAM Mid-Size Pharmaceutical Market Revenue Share, by Type (2022 and 2028)

7.3         Prescription

7.3.1        Overview

7.3.2        Prescription: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

7.4         Over-the-Counter (OTC)

7.4.1        Overview

7.4.2        Over-the-Counter: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

8.           SAM Mid-Size Pharmaceutical Market Analysis – By Drug Development Type

8.1         Overview

8.2         SAM Mid-Size Pharmaceutical Market Revenue Share, by Drug Development Type (2022 and 2028)

8.3         In-House

8.3.1        Overview

8.3.2        In-House: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

8.4         Outsource

8.4.1        Overview

8.4.2        Outsource: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

9.           SAM Mid-Size Pharmaceutical Market – By Formulation

9.1         Overview

9.2         SAM Mid-Size Pharmaceutical Market, by Formulation, 2022 and 2028 (%)

9.3         Tablets and Capsules

9.3.1        Overview

9.3.2        Tablets and Capsules: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

9.4         Injectables

9.4.1        Overview

9.4.2        Injectables: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

9.5         Sprays

9.5.1        Overview

9.5.2        Sprays: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

9.6         Other Formulations

9.6.1        Overview

9.6.2        Others: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

10.        SAM Mid-Size Pharmaceutical Market – By Therapy Class

10.1      Overview

10.2      SAM Mid-Size Pharmaceutical Market, by Therapy Class, 2022 and 2028 (%)

10.3      Cardiovascular Diseases

10.3.1     Overview

10.3.2     Cardiovascular Diseases: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

10.4      Pain Management

10.4.1     Overview

10.4.2     Pain Management: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

10.5      Diabetes

10.5.1     Overview

10.5.2     Diabetes: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

10.6      Cancer

10.6.1     Overview

10.6.2     Cancer: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

10.7      Other Diseases

10.7.1     Overview

10.7.2     Other Diseases: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

11.        SAM Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028 – Country Analysis

11.1      Overview

11.1.1     SAM: Mid-Size Pharmaceutical Market, by country, 2021 & 2028 (%)

11.1.1.1       Brazil: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (USD Million)

11.1.1.1.1       Brazil: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (USD Million)

11.1.1.1.2       Brazil: Mid-Size Pharmaceutical Market, by Type, 2019–2028 (USD Million)

11.1.1.1.3       Brazil: Mid-Size Pharmaceutical Market, by Drug Development Type, 2019–2028 (USD Million)

11.1.1.1.4       Brazil: Mid-Size Pharmaceutical Market, by Formulation, 2019–2028 (USD Million)

11.1.1.1.5       Brazil: Mid-Size Pharmaceutical Market, by Therapy Area, 2019–2028 (USD Million)

11.1.1.2       Argentina: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (USD Million)

11.1.1.2.1       Argentina: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (USD Million)

11.1.1.2.2       Argentina: Mid-Size Pharmaceutical Market, by Type, 2019–2028 (USD Million)

11.1.1.2.3       Argentina: Mid-Size Pharmaceutical Market, by Drug Development Type, 2019–2028 (USD Million)

11.1.1.2.4       Argentina: Mid-Size Pharmaceutical Market, by Formulation, 2019–2028 (USD Million)

11.1.1.2.5       Argentina: Mid-Size Pharmaceutical Market, by Therapy Area, 2019–2028 (USD Million)

11.1.1.3       Rest of SAM: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (USD Million)

11.1.1.3.1       Rest of SAM: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (USD Million)

11.1.1.3.2       Rest of SAM: Mid-Size Pharmaceutical Market, by Type, 2019–2028 (USD Million)

11.1.1.3.3       Rest of SAM: Mid-Size Pharmaceutical Market, by Drug Development Type, 2019–2028 (USD Million)

11.1.1.3.4       Rest of SAM: Mid-Size Pharmaceutical Market, by Formulation, 2019–2028 (USD Million)

11.1.1.3.5       Rest of SAM: Mid-Size Pharmaceutical Market, by Therapy Area, 2019–2028 (USD Million)

12.        Mid-Size Pharmaceutical Market–Industry Landscape

12.1      Overview

12.2      Growth Strategies Done by the Companies in the Market, (%)

12.3      Organic Developments

12.3.1     Overview

12.4      Inorganic Developments

12.4.1     Overview

13.        Company Profiles

13.1      DAIICHI SANKYO COMPANY LIMITED

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      Bausch Health Companies Inc.

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      Sun Pharmaceutical Industries Ltd

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      Alexion Pharmaceuticals, Inc.

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      Mallinckrodt

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      Endo Pharmaceuticals Inc.

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

14.        Appendix

14.1      About The Insight Partners

14.2      Glossary of Terms

LIST OF TABLES

Table 1.             Brazil: Mid-Size Pharmaceutical Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 2.             Brazil: Mid-Size Pharmaceutical Market, by Drug Development Type – Revenue and Forecast to 2028 (USD Million)

Table 3.             Brazil: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (USD Million)

Table 4.             Brazil: Mid-Size Pharmaceutical Market, by Therapy Area– Revenue and Forecast to 2028 (USD Million)

Table 5.             Argentina: Mid-Size Pharmaceutical Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 6.             Argentina: Mid-Size Pharmaceutical Market, by Drug Development Type – Revenue and Forecast to 2028 (USD Million)

Table 7.             Argentina: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (USD Million)

Table 8.             Argentina: Mid-Size Pharmaceutical Market, by Therapy Area– Revenue and Forecast to 2028 (USD Million)

Table 9.             Rest of SAM: Mid-Size Pharmaceutical Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 10.          Rest of SAM: Mid-Size Pharmaceutical Market, by Drug Development Type – Revenue and Forecast to 2028 (USD Million)

Table 11.          Rest of SAM: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (USD Million)

Table 12.          Rest of SAM: Mid-Size Pharmaceutical Market, by Therapy Area– Revenue and Forecast to 2028 (USD Million)

Table 13.          Organic Developments Done By Companies

Table 14.          Inorganic Developments Done By Companies

Table 15.          Glossary of Terms

LIST OF FIGURES

Figure 1.           SAM Mid-Size Pharmaceutical Segmentation

Figure 2.           SAM Mid-Size Pharmaceutical Segmentation, By Country

Figure 3.           SAM Mid-Size Pharmaceutical Overview

Figure 4.           Over-the-Counter Segment Held Largest Share by Type in SAM Mid-Size Pharmaceutical Market

Figure 5.           Brazil is Expected to Show Remarkable Growth During the Forecast Period

Figure 6.           SAM: PEST Analysis

Figure 7.           SAM Mid-Size Pharmaceutical Market– Revenue Forecast And Analysis – 2020- 2028

Figure 8.           SAM Mid-Size Pharmaceutical Market Revenue Share, by Type (2022 and 2028)

Figure 9.           SAM Prescription: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

Figure 10.        SAM Over-the-Counter: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

Figure 11.        SAM Mid-Size Pharmaceutical Market Revenue Share, by Drug Development Type (2022 and 2028)

Figure 12.        SAM In-House: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13.        SAM Outsource: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14.        SAM Mid-Size Pharmaceutical Market, by Formulation, 2022 and 2028 (%)

Figure 15.        SAM Tablets and Capsules: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16.        SAM Injectables: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17.        SAM Sprays: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18.        SAM Others: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19.        SAM Mid-Size Pharmaceutical Market, by Therapy Class, 2022 and 2028 (%)

Figure 20.        SAM Cardiovascular Diseases: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21.        SAM Pain Management: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22.        SAM Diabetes: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23.        SAM Cancer: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24.        SAM Other Diseases: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25.        SAM: Mid-Size Pharmaceutical Market, by Key Country – Revenue (2022) (US$' Million)

Figure 26.        SAM: Mid-Size Pharmaceutical Market, by country, 2021 & 2028 (%)

Figure 27.        Brazil: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (USD Million)

Figure 28.        Argentina: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (USD Million)

Figure 29.        Rest of SAM: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (USD Million)

Figure 30.        Growth Strategies Done by the Companies in the Market, (%)